A genetic map of an aggressive childhood brain tumour called medulloblastoma has helped researchers identify a new generation anti-cancer drug that can be repurposed as an effective treatment for the disease.
7 July 2021A University of Queensland scientist will help steer a national initiative striving to double brain cancer survival rates over the next decade.
31 January 2018A University of Queensland scientist whose pioneering work has helped unravel the complexity of the human genome and genetic traits has won a 2017 Prime Minister’s Prize for Science.
18 October 2017An international team of researchers has found a drug previously approved to treat breast cancer could also be used to shrink medulloblastoma, a common form of childhood brain tumour.
14 August 2017A future where no children suffer deadly brain tumours may be within reach, thanks to the vision of a team of researchers from The University of Queensland and generous funding.
2 November 2016Two companies founded on University of Queensland research have won acclaim at the National AusBiotech Conference in Melbourne.
31 October 2016University of Queensland spin-out biotech company Protagonist Therapeutics Inc is a step closer to developing a new drug that would benefit millions of people worldwide.
22 August 2016Professor Jenny Martin from the Institute for Molecular Bioscience is a finalist for a Pride of Australia Medal in the Inspiration category.
1 September 2015Scientists from Australia and the UK have completed the most comprehensive analysis yet of pancreatic cancer, in a study that could improve future treatments.
25 February 2015University of Queensland research to prevent, treat and diagnose a range of cancers has been boosted by the injection of $1.78 million in Cancer Council Queensland funding.
4 February 2015University of Queensland scientists have succeeded in identifying the major underlying mutations in pancreatic and ovarian cancers, two of Australia’s most ruthless cancers.
8 July 2014Research projects understanding how cells migrate and developing improved treatments for drug-resistant tuberculosis have been recognised as some of the best in the country by the National Health and Medical Research Council (NHMRC).
1 November 2013